| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Medicine,*
New York Medical
College, Valhalla, New York, the Department of Pathology, Anatomy, and
Cell Biology and Institute for Cancer Research and Molecular
Medicine,
Jefferson Medical College,
Philadelphia, Pennsylvania, and the Department of
Medicine,
Montefiore Medical Center and
Albert Einstein College of Medicine, New York, New York
Insulin-like growth factor (IGF)-1 inhibits apoptosis, but its mechanism is unknown. Myocyte stretching activates p53 and p53-dependent genes, leading to the formation of angiotensin II (Ang II) and apoptosis. Therefore, this in vitro system was used to determine whether IGF-1 interfered with p53 function and the local renin-angiotensin system (RAS), decreasing stretch-induced cell death. A single dose of 200 ng/ml IGF-1 at the time of stretching decreased myocyte apoptosis 43% and 61% at 6 and 20 hours. Ang II concentration was reduced 52% at 20 hours. Additionally, p53 DNA binding to angiotensinogen (Aogen), AT1 receptor, and Bax was markedly down-regulated by IGF-1 via the induction of Mdm2 and the formation of Mdm2-p53 complexes. Concurrently, the quantity of p53, Aogen, renin, AT1 receptor, and Bax was reduced in stretched myocytes exposed to IGF-1. Conversely, Bcl-2 and the Bcl-2-to-Bax protein ratio increased. The effects of IGF-1 on cell death, Ang II synthesis, and Bax protein were the consequence of Mdm2-induced down-regulation of p53 function. In conclusion, the anti-apoptotic impact of IGF-1 on stretched myocytes was mediated by its capacity to depress p53 transcriptional activity, which limited Ang II formation and attenuated the susceptibility of myocytes to trigger their endogenous cell death pathway.
This article has been cited by other articles:
 |
|
 |
|
  D. M. Gilkes, Y. Pan, D. Coppola, T. Yeatman, G. W. Reuther, and J. Chen Regulation of MDMX Expression by Mitogenic Signaling Mol. Cell. Biol., March 15, 2008; 28(6): 1999 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xiong, F. Kou, Y. Yang, and J. Wu A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop J. Cell Biol., September 7, 2007; 178(6): 995 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chung, E. Kim, D. H. Lee, S. Seo, S. Ju, D. Lee, H. Kim, and S. Park Ghrelin Inhibits Apoptosis in Hypothalamic Neuronal Cells during Oxygen-Glucose Deprivation Endocrinology, January 1, 2007; 148(1): 148 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Zolk, C. Schenke, and A. Sarikas The ubiquitin-proteasome system: Focus on the heart Cardiovasc Res, June 1, 2006; 70(3): 410 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Toth, P. Nickson, L. L. Qin, and P. Erhardt Differential Regulation of Cardiomyocyte Survival and Hypertrophy by MDM2, an E3 Ubiquitin Ligase J. Biol. Chem., February 10, 2006; 281(6): 3679 - 3689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Decraene, R. Benchaouir, M.-A. Dillies, D. Israeli, S. Bortoli, C. Rochon, P. Rameau, A. Pitaval, D. T.-L. Roux, O. Danos, et al. Global transcriptional characterization of SP and MP cells from the myogenic C2C12 cell line: effect of FGF6 Physiol Genomics, October 17, 2005; 23(2): 132 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brady, N. Vlatkovic, and M. T. Boyd Regulation of p53 and MDM2 Activity by MTBP Mol. Cell. Biol., January 15, 2005; 25(2): 545 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Paajarvi, M. Viluksela, R. Pohjanvirta, U. Stenius, and J. Hogberg TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents Carcinogenesis, January 1, 2005; 26(1): 201 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-S. Leung, W. J. Aronson, T. H. Ngo, L. A. Golding, and R. J. Barnard Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro J Appl Physiol, February 1, 2004; 96(2): 450 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Finnberg, I. Silins, U. Stenius, and J. Hogberg Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions Carcinogenesis, January 1, 2004; 25(1): 113 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. S. Kang, A. Urbonas, A. Baddoo, S. Baskin, A. Malhotra, and L. G. Meggs IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose Am J Physiol Renal Physiol, November 1, 2003; 285(5): F1013 - F1024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Husse, A. Sopart, and G. Isenberg Cyclical mechanical stretch-induced apoptosis in myocytes from young rats but necrosis in myocytes from old rats Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1521 - H1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Dean, L. A. Bach, and L. M. Burrell Upregulation of Cardiac Insulin-like Growth Factor-I Receptor by ACE Inhibition After Myocardial Infarction: Potential Role in Remodeling J. Histochem. Cytochem., June 1, 2003; 51(6): 831 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Decraene, P. Agostinis, R. Bouillon, H. Degreef, and M. Garmyn Insulin-like Growth Factor-1-mediated AKT Activation Postpones the Onset of Ultraviolet B-induced Apoptosis, Providing More Time for Cyclobutane Thymine Dimer Removal in Primary Human Keratinocytes J. Biol. Chem., August 30, 2002; 277(36): 32587 - 32595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Heron-Milhavet and D. LeRoith Insulin-like Growth Factor I Induces MDM2-dependent Degradation of p53 via the p38 MAPK Pathway in Response to DNA Damage J. Biol. Chem., May 3, 2002; 277(18): 15600 - 15606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Welch, D. Plank, S. Witt, B. Glascock, E. Schaefer, S. Chimenti, A. M. Andreoli, F. Limana, A. Leri, J. Kajstura, et al. Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice Circ. Res., April 5, 2002; 90(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. L. Janssen, G. Hasenfuss, O. Zeitz, S. E. Lehnart, J. Prestle, D. Darmer, J. Holtz, and H. Schumann Load-dependent induction of apoptosis in multicellular myocardial preparations Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H349 - H356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Goetz, H. van der Kuip, R. Maya, M. Oren, and W. E. Aulitzky Requirement for Mdm2 in the Survival Effects of Bcr-Abl and Interleukin 3 in Hematopoietic Cells Cancer Res., October 1, 2001; 61(20): 7635 - 7641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Vickers, B. A. Ikenasio, and B. H. Breier IGF-I Treatment Reduces Hyperphagia, Obesity, and Hypertension in Metabolic Disorders Induced by Fetal Programming Endocrinology, September 1, 2001; 142(9): 3964 - 3973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Malhotra, B. P.S. Kang, S. Cheung, D. Opawumi, and L. G. Meggs Angiotensin II Promotes Glucose-Induced Activation of Cardiac Protein Kinase C Isozymes and Phosphorylation of Troponin I Diabetes, August 1, 2001; 50(8): 1918 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kajstura, F. Fiordaliso, A. M. Andreoli, B. Li, S. Chimenti, M. S. Medow, F. Limana, B. Nadal-Ginard, A. Leri, and P. Anversa IGF-1 Overexpression Inhibits the Development of Diabetic Cardiomyopathy and Angiotensin II-Mediated Oxidative Stress Diabetes, June 1, 2001; 50(6): 1414 - 1424. [Abstract] [Full Text]
|
|
|
|
|
|
M. Palmen, M.J.A.P. Daemen, R. Bronsaer, W.R.M. Dassen, H.R. Zandbergen, M. Kockx, J.F.M. Smits, R. van der Zee, and P.A. Doevendans Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice Cardiovasc Res, June 1, 2001; 50(3): 516 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Babuty and M. J Lab Mechanoelectric contributions to sudden cardiac death Cardiovasc Res, May 1, 2001; 50(2): 270 - 279. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dalla Libera, B. Ravara, A. Angelini, K. Rossini, M. Sandri, G. Thiene, G. Battista Ambrosio, and G. Vescovo Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure Circulation, May 1, 2001; 103(17): 2195 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Barlucchi, A. Leri, D. E. Dostal, F. Fiordaliso, H. Tada, T. H. Hintze, J. Kajstura, B. Nadal-Ginard, and P. Anversa Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure Circ. Res., February 16, 2001; 88(3): 298 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ravassa, M. A. Fortuno, A. Gonzalez, B. Lopez, G. Zalba, A. Fortuno, and J. Diez Mechanisms of Increased Susceptibility to Angiotensin II-Induced Apoptosis in Ventricular Cardiomyocytes of Spontaneously Hypertensive Rats Hypertension, December 1, 2000; 36(6): 1065 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leri, F. Fiordaliso, M. Setoguchi, F. Limana, N. H. Bishopric, J. Kajstura, K. Webster, and P. Anversa Inhibition of p53 Function Prevents Renin-Angiotensin System Activation and Stretch-Mediated Myocyte Apoptosis Am. J. Pathol., September 1, 2000; 157(3): 843 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Leri, Y. Liu, B. Li, F. Fiordaliso, A. Malhotra, R. Latini, J. Kajstura, and P. Anversa Up-Regulation of AT1 and AT2 Receptors in Postinfarcted Hypertrophied Myocytes and Stretch-Mediated Apoptotic Cell Death Am. J. Pathol., May 1, 2000; 156(5): 1663 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Haunstetter and S. Izumo Toward Antiapoptosis as a New Treatment Modality Circ. Res., March 3, 2000; 86(4): 371 - 376. [Full Text] [PDF]
|
|
|
|
|
|
L. J. De Windt, H. W. Lim, T. Taigen, D. Wencker, G. Condorelli, G. W. Dorn II, R. N. Kitsis, and J. D. Molkentin Calcineurin-Mediated Hypertrophy Protects Cardiomyocytes From Apoptosis In Vitro and In Vivo : An Apoptosis-Independent Model of Dilated Heart Failure Circ. Res., February 18, 2000; 86(3): 255 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Dispersyn, M. Borgers, and W. Flameng Apoptosis in chronic hibernating myocardium: sleeping to death? Cardiovasc Res, February 1, 2000; 45(3): 696 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schumann, J. Holtz, H.-R. Zerkowski, and M. Hatzfeld Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression Cardiovasc Res, February 1, 2000; 45(3): 720 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Oren Regulation of the p53 Tumor Suppressor Protein J. Biol. Chem., December 17, 1999; 274(51): 36031 - 36034. [Full Text] [PDF]
|
|
|
|
|
|
S. Welch, D. Plank, S. Witt, B. Glascock, E. Schaefer, S. Chimenti, A. M. Andreoli, F. Limana, A. Leri, J. Kajstura, et al. Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice Circ. Res., April 5, 2002; 90(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
